COMPANY
About Us
We make genomics accessible for everyone
Dante Omics is a leading global genomics and precision medicine company working to accelerate science to deliver better healthcare and ultimately save lives with a more human approach to health.
Our mission is to leverage whole genome sequencing technology and variant interpretation, so that you can make informed decisions about your health and your future.
Quality services for any need
5.000.000+ Covid Samples
200+ Reviews
Active in 6 countries
A Few Words About Us
Our Story
Founded by two Italian co-founders in 2016, the company name, Dante Omics, comes from the compound of humanity and science. “Dante” refers to the famous Italian humanitarian poet and “Genomics” refers to the powerful science that takes place in a genomics lab. Since its foundation, Dante Omics has delivered hundreds of thousands of people with affordable, quality genomic solutions to inform their healthcare decisions. The Company’s holistic approach to medicine spans from sequencing and variant interpretation to drug discovery and development.
2016
Founded by two Italian co-founders
2017
Lower the price of Whole Genome Sequencing (WGS) and interpretation
2018
Expands its full DNA test with proprietary analysis of Mitochondrial and Neurological diseases
2019
Launches the first Whole Genome Report powered by Artificial Intelligence
2020
Best in class Covid analysis service provider
2021
Acquires Cambridge Cancer Genomics to create Global excellence in precision oncology
2022
Enhances its Whole Genome Sequencing test with a broader, more comprehensive offering
2023
Introduces proteomics to integrate genomic and protein-level data for multi-omics analysis
2024
Expands laboratory capabilities by adopting MGI sequencing platforms alongside Illumina technologies, increasing throughput and flexibility
2025
Launches spatial omics and single-cell technologies (e.g., STOmics) to enable tissue-level resolution and cellular mapping in genomics research
“Our mission is to leverage whole genome sequencing technology and variant interpretation, so that you can make informed decisions about your health and your future.”
ANDREA RIPOSATI
Founders & Labs
Our mission is to leverage whole genome sequencing technology and variant interpretation, so that you can make informed decisions about your health and your future.
Chief Executive Officer & Co-founder
Chief Scientific Officer & Co-founder
WHAT WE DO
Personalized medicine needs personalized data
Software
Take raw data and translate that intro clinical decision-making tools and reports
Diagnostics
Analyze and interpret the whole genome to diagnose and inform on heritable diseases
Drug Development
Utilize genomic data to create novel drugs and therapies in order to better treat disease